NOTE*** Starting today at 9:30 AM and this week we are featuring (OTCBB: MMPW) to our members. Analyst report MMPW– https://broadstreetalerts.com/wp-content/uploads/2016/02/MMPW-Analyst-Target-1.pdf
About Broad Street Alerts:
Big opportunities in Small Cap’s in a down market
Broadstreetalerts.com recent profiles and track record, 157% in verifiable potential gains for our members in December 2015 alone.
December 29th, 2015- (NASDAQ: INVT) opened $1.35/share hit a high midday of $2.82/share over 100% in gains for our members.
December 15th, 2015-(NYSE-MKT: XXII) opened at $1.29 hit a high of $1.54 within 3 days for gains of 19% for our members.
December 2nd, 2015- (NASDAQ: TCCO) opened at $3.25 hit a high of $4.50 within 3 days for 38% gains for our members.
These are numbers that make traders drool. Any trader in any market would fall all over themselves to see numbers like this. So if you’ve been on the fence, perhaps it’s time to start doing some research and verify our numbers for yourself. We are constantly raising the bar and separate ourselves from the rest of the small-cap newsletters as the best in business. We know with a large following comes a large responsibility as we have everyone from institutional investors to the beginner following our profiled securities in our newsletters. This is something we take very seriously always seeking small cap growth companies that have both near and long-term potential for our members.
***Get our small cap profiles, special situation and watch alerts in real time. We are now offering our VIP SMS/text alert service for free, simply text the word “Alerts” to the phone number 25827 from your cell phone.
Brief Report for Arcis Resources Corporation (OTCBB: ARCS)
Last month the company that it has acquired www.vapeoutlet.co. It sells premium portable & desktop vaporizers, E-juice, oils & accessories. Since 2008, the number of U.S. vape shops has grown to about 8,500, and the sale of electronic cigarettes and supplies climbed to $3.5 billion. A lot of analysts expect the use of e-cigarettes and vaporizers to overtake combustible cigarettes in 10 years. Vapeoutlet.co is profitable, and has revenue in the thousands. It will implement improved SEO, PPC and strategic Instagram to add to revenue growth.
This month ARCS disclosed that it has record web analytics for www.vapeoutlet.co. The site has a global rank of 424,572 on www.alexa.com. The company is currently reinvesting all its sales on marketing efforts to increase its bottom line. In addition, the company is on track to launch its hemp infused energy drinks for 1st quarter of 2016. The energy drinks will contain hemp infused seed oil. Fatty acids in hemp oil are associated with health benefits that include protection against heart disease, cancer, bowel disease and other auto immune diseases.
Brief Report for Intellipharmaceutics International Inc. (NASDAQ: IPCI)
The company has announced that pivotal bioequivalence trials of the Company’s Rexista™ Oxycodone XR (abuse deterrent oxycodone hydrochloride) extended release tablets, dosed under fasted and fed conditions, had demonstrated bioequivalence to Oxycontin® (oxycodone hydrochloride) extended release tablets as manufactured and sold in the United States by Purdue Pharma LP. The study design was based on United States Food and Drug Administration (“FDA”) recommendations and compared the lowest and highest strengths of exhibit batches of the Company’s Rexista™ Oxycodone XR to the same strengths of Oxycontin®. The results show that the ratios of the pharmacokinetic metrics, Cmax, AUC0-t and AUC0-f for Rexista™ vs. Oxycontin®, are within the interval of 80% – 125% required by the FDA with a confidence level exceeding 90%.
The Company had earlier announced, in March 2015, that topline data results of three definitive Phase I pharmacokinetic clinical trials (single dose fasting, single dose steady-state fasting, and single dose fed), conducted on pilot batches of the Company’s Rexista™ Oxycodone XR, all met the FDA bioequivalence criteria when compared to the existing branded drug Oxycontin®.
The Company had also earlier announced, in May 2015, that the FDA had provided the Company with notification regarding its Investigational New Drug Application (“IND”) submission for Rexista™ Oxycodone XR. The notification from the FDA had stated that the Company would not be required to conduct Phase III studies if bioequivalence to Oxycontin® was demonstrated.
Having now demonstrated such bioequivalence for its Rexista™ Oxycodone XR product to be marketed upon FDA approval, the Company intends to complete the regulatory filing requirements and file a New Drug Application (“NDA”) for Rexista™ Oxycodone XR with the FDA within the next 6 months in accordance with the NDA 505(b)(2) regulatory pathway. There can be no assurance that the FDA will ultimately approve the NDA for the sale of Rexista™ Oxycodone XR in the U.S. market, or that it will ever be successfully commercialized.
Brief Report for Sphere 3D Corp. (NASDAQ: ANY)
Surpass, LLC, a national call center headquartered in Lynchburg, VA will upgrade two of its call centers with Sphere 3D’s hybrid cloud offerings.
According to Peter Bookman, Global Strategist at Sphere 3D, “At Surpass, we believe the key to our growth is providing world class service to our clients while maximizing operating efficiencies. We are excited to bring Sphere 3D’s hybrid cloud solutions into our newest 80-seat call center located in Lynchburg, VA. Additionally, we plan on leveraging their portfolio of services to modernize our current facility without replacing any of our existing hardware,” said Ken Mnemcovich, President at Surpass, LLC. “Sphere 3D’s portfolio supports the flexibility to purchase in a bundled price or a la carte depending on our real time requirements. We anticipate our callers’ average call time (ACT) will shorten and deliver optimal results for our clients. We now have the tools we need to support our virtual desktops while providing secure access to our client data both onsite and in the Microsoft Azure cloud.”
Surpass will deploy a complete hybrid cloud solution that includes Sphere 3D’s V3™ virtual desktop appliances, integrated with software from VMware and managed by Sphere 3D’s Desktop Cloud Orchestrator™ (DCO); 80 seats of Glassware 2.0™ containers for applications virtualization; SnapServer® physical storage for shared storage; and the SnapCLOUD™ virtual storage service in Microsoft Azure.
Surpass will be able to take advantage of a comprehensive cloud solution that offers simple deployment and management while maintaining the ability to scale out as needed. Although this approach provides a complete hybrid cloud experience, it’s delivered at a low total cost of ownership; with the initial call center deployment costing just over $150,000 U.S.
Brief Report for The Pulse Network, Inc. (OTCBB: TPNI)
Excerpted from TPNI Form 8-K Submitted January 27, 2016
On January 4, 2016 and effective December 3, 2015, The Pulse Network, Inc., a Nevada Corporation (the “Company”) and TCA Global Credit Master Fund, LP, a Cayman Islands limited partnership (“TCA”) entered into that certain Third Amendment to the Purchase Agreement (the “Third Amendment”) originally entered into on September 30, 2014 (the “Original Purchase Agreement”), together with First Amendment to the Purchase Agreement dated as of December 16, 2014 (the “First Amendment”), and Second Amendment to the Purchase Agreement dated as of April 1, 2015 (the “Second Amendment”) (the Original Purchase Agreement, the First Amendment, and the Second Amendment, together with any other amendments, renewals, substitutions, replacements or modifications from time to time, collectively, the “Purchase Agreement”), pursuant to which the Company issued TCA that certain Third Replacement Revolving Note A, dated December 3, 2015 (the “Third Replacement Revolving Note A”) TCA that certain Third Replacement Revolving Note B, dated December 3, 2015 (the “Third Replacement Revolving Note B”)(collectively, the “Two Third Replacement Revolving Notes”), both of which collectively which amended, restated and superseded the existing Second Replacement Revolving Note issued to TCA on April 1, 2015. The purpose and primary effect of the transactions described above is that the Company was able to reduce its monthly payments due to TCA from $135,000 per month to $50,000 per month.
The Two Third Replacement Revolving Notes are substantially in the same form as Second Replacement Revolving Note but contain a revised payment schedules pursuant to which the Company must make certain daily payments until maturity on December 3, 2016. The Two Third Replacement Revolving Notes pay interest at a rate of 11% per annum. At any time while either of the Two Third Replacement Revolving Notes are outstanding, upon the occurrence of an Event of Default (as defined in the Two Third Replacement Revolving Notes), TCA or any other holder of either of the Two Third Replacement Revolving Notes, may convert all or any portion of the outstanding principal accrued and unpaid interest and any other sums due and payable or under any of the other Transaction Documents (such total amount, the “Conversion Amount”) into shares of Common Stock of the Company (the “Conversion Shares”) at a price equal to: (i) the Conversion Amount (the numerator); divided by(ii) eighty-five percent (85%) of the lowest volume weighted average price of the Company’s Common Stock during the five (5) trading days immediately prior to the conversion date, as indicated in the conversion notice (the denominator) (the “Conversion Price”).
Simultaneously with and in connection with entering into the Purchase Agreement and making the Two Third Replacement Revolving Notes, the Company entered into that certain Debt Purchase Agreement (the “Debt Purchase Agreement”), dated December 31, 2015, by and among the Company, TCA and Rockwell Capital Partners (“Rockwell”), pursuant to which TCA assigned to Rockwell $300,000 of debt (the “Assigned Debt”) evidenced by that certain that certain Second Replacement Revolving Note, dated as of April 1, 2015, in the principal amount of $2,828,037.03 made by the Company to TCA. Under the Debt Purchase Agreement, the Assigned Debt will be assigned from TCA to Rockwell in six tranches of $50,000 each, with the first tranche having been assigned with the execution of the Debt Purchase Agreement, and tranches two though six, taking place 30 days after the assigned of the prior $50,000 tranche assignment.
On January 25, 2016, pursuant to the terms and conditions of the Debt Purchase Agreement, the Company made that certain Fourth Replacement Revolving Note A, dated January 21, 2016, in the principal sum of $50,000 (the “Third Replacement Revolving Note A”) that certain Fourth Replacement Revolving Note A, dated January 21, 2016, in the principal sum of $1,867,589.48 (collectively, the “Two Fourth Replacement Revolving Notes”). Two Fourth Replacement Revolving Notes replace the Two Third Replacement Revolving Notes.
The Two Fourth Replacement Revolving Notes pay interest at a rate of 11% per annum. At any time while either of the Two Fourth Replacement Revolving Notes are outstanding, upon the occurrence of an Event of Default (as defined in the Two Fourth Replacement Revolving Notes), TCA or any other holder of either of the Two Fourth Replacement Revolving Notes, may convert all or any portion of the outstanding principal accrued and unpaid interest and any other sums due and payable or under any of the other Transaction Documents (such total amount, the “Conversion Amount”) into shares of Common Stock of the Company (the “Conversion Shares”) at a price equal to: (i) the Conversion Amount (the numerator); divided by(ii) eighty-five percent (85%) of the lowest volume weighted average price of the Company’s Common Stock during the five (5) trading days immediately prior to the conversion date, as indicated in the conversion notice (the denominator) (the “Conversion Price”).
As further consideration for TCA entering into the Third Amendment and structuring the Purchase Agreement, the Company paid TCA an advisory fee of $500,000 by issuing to TCA 500,00 shares of its Series C Convertible Preferred Stock. A copy of the Certificate of Designation of the Rights, Preferences, Privileges and Restrictions of Series D Convertible Preferred Stock is filed as an exhibit to this Form 8-K.
DISCLAIMER
Broad Street Alerts has compensated the author of this report (LIX Research Group) up to two hundred and fifty dollars for the redistribution rights for a period of up to 30 days.
BroadStreetAlerts.com is a wholly owned subsidiary of Small Cap Specialists LLC, herein referred to as SCS LLC. NOTE* SCS LLC has not been compensated for the mention of ANY, TPNI, IPCI and ARCS. We were previously compensated up to ninety thousand dollars for the mention of INVT and XXII on two seperate occasions however those contracts have since expired. SCS LLC has been compensated fifteen thousand dollars by Cream Consulting, LLC for a two day investor relations program of MMPW starting 2/26/16.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. We have not been compensated in any form by any entity for this report. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
PLEASE NOTE WELL: SCS LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold SCS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. SCS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SCS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead SCS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. SCS LLC is compliant with the Can Spam Act of 2003. SCS LLC does not offer such advice or analysis, and SCS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects”, “foresee”, “expects”, “will”, “anticipates”, “estimates”, “believes”, “understands”, or that by statements indicating certain actions & quote; “may”, “could”, or “might” occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, SCS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, SCS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. SCS LLC is not responsible for any claims made by the companies advertised herein, nor is SCS LLC responsible for any other promotional firm, its program or its structure.
SCS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA. SCS LLC is not a Broker/Dealer and does not engage in high frequency trading.
